WSWest Pharmaceutical Services WST · NYSE
$383.83 +0.21% (+$0.81)
- Market cap
- $27.0B
- Enterprise value
- $26.9B
- P/E
- 47.8x
- Forward P/E
- 41.4x
- PEG
- 269.2x
- P/S
- 8.1x
- P/FCF
- 61.8x
- EV/EBITDA
- 32.6x
- ROIC
- 15.8%
- Gross margin
- 36.8%
- Net margin
- 17.0%
- Dividend yield
- 0.23%
- Payout ratio
- 11.0%
- Net debt/EBITDA
- -0.2x
- Beta
- 1.13
- Free float
- 99.3%
About the company
West Pharmaceutical Services, Inc. (WST) is an American company specializing in the development and manufacturing of technologies and components for the pharmaceutical and biotechnology industries. The company focuses on producing innovative and safe systems for drug packaging and administration, including syringe systems, elastomeric closures, and other pharmaceutical products. West Pharmaceutical Services is a key partner for pharmaceutical companies, helping them ensure the safe and effective delivery of therapeutic agents. West Pharmaceutical Services, Inc. (WST) shares could be suitable for investors looking to invest in the pharmaceutical sector and healthcare technologies.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Michel Lagarde
Employees
10,800
Headquarters
Exton
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number